Coronavirus News Roundup: US Unveils COVID-19 Vaccine Rollout Strategy, AstraZeneca Vaccine Trial Resumes

Article

Here's this week's coronavirus-related news you should know.

COVID-19 test

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 30,290,791 individuals worldwide, and approximately 6.7 million Americans. The latest COVID-19 related news includes the US government’s COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations debuting its rollout strategy for a COVID-19 vaccine, and a study that assessed Americans’ willingness to receive a COVID-19 vaccine once available.

Here’s a roundup of the latest coronavirus-related news:

US COVID-19 Vaccine Rollout Strategy Unveiled

Pharmacies are one of the key commercial partners that the Trump administration included in its new COVID-19 vaccine interim distribution plan.

The government’s COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations provides a strategic distribution overview along with guidelines for state, tribal, territorial, and local public health programs and their partners on how to plan and operationalize a vaccination response to COVID-19.

Read more

Pharmacy Employees: Essential Workers Amid Pandemic but Often Overlooked

“Since I’ve been teaching a class of 55 physician assistants for the past 15 years, I’ve come to know some of them very well. One of my former students and I were discussing COVID-19 mayhem. He said, “It has taught me the difference between essential versus expendable personnel.”

Read more

Quest, Albertsons Make At-Home COVID-19 Tests Available

Labs and drug stores are making at-home COVID-19 tests more accessible.

Quest Diagnostics said consumers can now purchase its QuestDirect COVID-19 Active Infection test online with specimen collection at home or at Walmart Neighborhood Market pharmacies.

Read more

Expert Interview: Medication Adherence Amid COVID-19

Heidi Polek, strategic program manager at DrFirst, discusses with Drug Topics® the impact that the COVID-19 pandemic is having on chronic conditions and medication adherence.

Watch the interview

Baricitinib Plus Remdesivir Improves Recovery Time for Hospitalized COVID-19

Baricitinib (Olumiant; Eli Lilly) in combination with remdesivir reduced time to recovery in hospitalized patients with COVID-19 when compared with remdesivir, according to initial data from the Adaptive COVID-19 Treatment Trial (ACTT-2).

Read more

Study Evaluates Americans’ Willingness to Receive COVID-19 Vaccine

Results of a recent study showed that approximately 7 in 10 Americans are willing to get a COVID-19 vaccine once available.

This interest is higher than what is typically seen for other vaccines, such as the flu vaccine; however, the investigators noted concerning gaps.

Read more

AstraZeneca Resumes COVID-19 Vaccine Trial After Safety Review

A clinical trial evaluating AstraZeneca’s COVID-19 vaccine candidate AZD1222 in the UK has resumed after the study was put on hold last week.

The vaccine trial, which is currently in phase 3 stages, was paused following reports that a serious adverse event hospitalized a UK participant. Trial investigators have resumed clinical trials following confirmation from independent reviewers that it was safe to do so.

Read more

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.